logo

Biosig Technologies, Inc. (BSGM)



Trade BSGM now with
  Date
  Headline
9/30/2020 9:25:34 AM ViralClear, Sorrento Explore Combination Antibody Plus Antiviral Therapy Against COVID-19
7/1/2020 9:18:02 AM BioSig Technologies Adds Tony Zook To Board
6/29/2020 8:20:05 AM BioSig Closes On Sale Of 2.18 Mln Shares Of Common Stock
6/24/2020 9:25:07 AM BioSig Technologies Plans $17.5 Mln Common Stock Only Registered Direct Offering
6/17/2020 10:47:29 AM Stock Alert: BioSig Gains 7%
6/17/2020 8:00:22 AM ViralClear Begins Patient Enrollment With Dosing Of First Patient In Phase II Trial For Merimepodib
5/18/2020 8:37:49 AM ViralClear Pharma: FDA Clears IND To Enable Phase II Trial Of Merimepodib To Proceed
4/24/2020 9:35:37 AM ViralClear Submits IND For Phase II Clinical Trials For Merimepodib For COVID-19
10/15/2019 7:56:10 AM BioSig Technologies Opens New Technology Development Office At Discovery Square
9/26/2019 7:57:18 AM BioSig Technologies Appoints Martha Pease As An Independent Director
7/11/2019 8:06:40 AM BioSig Technologies Names Manasi Patwardhan Director Of Strategic Planning
6/3/2019 8:21:41 AM BioSig Technologies Receives Total Of $4.6 Mln In Warrant And Option Exercises
4/9/2019 7:58:41 AM Frank Quintero Joins BioSig Technologies Advisory Board